FDA Adverse Event Injury Summary report: N

ADVANTAGE PLUS

MDR report key: 8684983 · Received June 10, 2019

Report

Report Number
2150060-2019-00048
Event Type
Injury
Date Received
June 10, 2019
Date of Event
May 20, 2019
Report Date
June 10, 2019
Manufacturer
MEDIVATORS INC.
Product Code
FEB
UDI-DI
00677964044755
PMA / PMN Number
K102996
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 1

MEDIVATORS SALES REPRESENTATIVE REPORTED A FACILITY USING PROLYSTICA ENZYMATIC INSTRUMENT DETERGENT IN THEIR ADVANTAGE PLUS AUTOMATED ENDOSCOPE REPROCESSOR (AER). PROLYSTICA DETERGENT IS NOT VALIDATED FOR USE WITH THE ADVANTAGE PLUS AER. PER THE AER IFU, ONLY INTERCEPT DETERGENT IS VALIDATED FOR USE IN THE CLEANING CYCLE OF THE AER, THEREFORE THERE IS POTENTIAL THAT THE ENDOSCOPES CLEANED WITH PROLYSTICA DETERGENT WERE NOT ADEQUATELY REPROCESSED. IT IS UNKNOWN HOW LONG THE FACILITY HAS BEEN USING PROLYSTICA WITH THEIR ADVANTAGE PLUS AER. IT WAS REPORTED THAT THE FACILITY OTHERWISE FOLLOWS APPROPRIATE REPROCESSING PROCESSES. MEDIVATORS FIELD SERVICE REPRESENTATIVE INSTRUCTED THE FACILITY TO DISCONTINUE USE OF PROLYSTICA DETERGENT WITH THE ADVANTAGE PLUS AER. THERE HAVE BEEN NO REPORTS OF PATIENT HARM. THIS COMPLAINT WILL CONTINUE TO BE MONITORED IN THE MEDIVATORS COMPLAINT HANDLING SYSTEM.

Description of Event or Problem · 1

MEDIVATORS SALES REPRESENTATIVE REPORTED A FACILITY USING PROLYSTICA ENZYMATIC INSTRUMENT DETERGENT IN THEIR ADVANTAGE PLUS AUTOMATED ENDOSCOPE REPROCESSOR (AER). PROLYSTICA DETERGENT IS NOT VALIDATED FOR USE WITH THE ADVANTAGE PLUS AER. PER THE AER IFU, ONLY INTERCEPT DETERGENT IS VALIDATED FOR USE IN THE CLEANING CYCLE OF THE AER, THEREFORE THERE IS POTENTIAL THAT THE ENDOSCOPES CLEANED WITH PROLYSTICA DETERGENT WERE NOT ADEQUATELY REPROCESSED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
479028 ADVANTAGE PLUS AUTOMATED ENDOSCOPE REPROCESSOR FEB MEDIVATORS INC. 00677964044755

Patients

Seq Age Sex Outcome Treatment
1 Other